Theralase Technologies Inc. V.TLT

Q221 Financial Statement Highlights

[floatinketucky]

For the 9 months ended September 30th, 2021 Total operating expenses 3,379,146

3,379,146CAD / 9 months = Monthy burn rate  CAD 375,460.00 per month.

This is a very low burn rate. 

Theralase has backers who exercise warrents when the compnay needs money.
It's been that way for years.  That's why they are well into a phase 2 study WITHOUT DEBT. 

Quarterly Newsletter 2Q2021.pdf    PG 2

[floatinketucky]

The Anti-Cancer Therapy (“ACT”) division represented $2,325,340 of this loss (74%) for the nine-month period ended September 30, 2021. Financial highlights for the 9 month period ended September 30, 2021: Unaudited Consolidated Statements of Operations 2021 2020 Change In Canadian Dollars $ $ %  

[floatinketucky]